Answers are grounded in this paper and cite their sources.
Background: Olfactory neuroblastoma is a rare malignancy of the nasal cavity. Methods: We describe a case of radiation-induced olfactory neuroblastoma in a patient with a history of radiation for Graves’ ophthalmopathy. We also reviewed the literature and found four other cases of radiation-induced olfactory neuroblastoma reported since 2000, suggesting prior radiotherapy as one risk factor for this disease. Results: We treated the patient with multimodality treatment consisting of surgery, radiotherapy and chemotherapy (6 cycles of cisplatin/etoposide). Despite the previously irradiation, treatment was well tolerated without excessive short or long term radiation toxicity. The patient remains in long term remission with no evidence of loco-regional recurrence or systemic metastasis after 12 years of follow-up. Conclusions: Prior radiotherapy appears to be a risk factor in a handful of cases of this rare malignancy. Although the literature is limited for radiation-related olfactory neuroblastoma, outcomes appear generally poorer for this group but highly variable. With careful patient selection, aggressive multi-modality therapy including post-operative radiotherapy may be feasible.
No takes yet. Share an insight, caveat, or question.
Tamjid et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: